Press release
Neuromodulation Market to 2025 | Top Key Players are Abbott, Boston Scientific Corporation, Integer Holdings Corporation, Magstim, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., Nevro Corp
Neuromodulation Market is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.Get Sample Copy of this Report at: http://bit.ly/2yeKxmP
Rising cases of neurological disorders and growth in the geriatric population is expected to propel the neuromodulation market growth in the coming years. Technological advancements and the rising cases of Alzheimer and Parkinson's disease is expected to offer significant growth opportunities in the neuromodulator market during the forecast period.
Leading Neuromodulation Market Players:
1. Abbott
2. Boston Scientific Corporation
3. Integer Holdings Corporation
4. Magstim
5. Medtronic
6. NeuroPace, Inc.
7. NeuroSigma, Inc.
8. Nevro Corp.
9. Synapse Biomedical Inc.
10. Soterix Medical Inc.
The "Global Neuromodulation Market Analysis to 2025" is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global neuromodulation market with detailed market segmentation by technology, end user, and geography. The global neuromodulation market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global neuromodulation market is segmented on the basis of technology end user. Based on technology, the neuromodulation market is segmented as, external (non-invasive) neuromodulation and internal neuromodulation. The segment of external (non-invasive) neuromodulation is further classified as, respiratory electrical stimulation (RES), transcutaneous electrical nerve stimulation (TENS) and transcranial magnetic stimulation (TMS). Internal neuromodulation is further classified as, deep brain stimulation (DBS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). Based on end user, neuromodulation market is segmented as, hospitals, clinics and home healthcare.
The neuromodulation market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neuromodulation market based technology, and end user. It also provides market size and forecast till 2025 for overall neuromodulation market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The neuromodulation market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
Inquire about this Report at: http://bit.ly/2RmFQjE
North America is expected to contribute to the largest share in the neuromodulation market in the coming years, owing to increasing ageing population in the US and availability of better healthcare services. The demand for neuromodulation market in Asia Pacific is expected to witness significant growth during the forecast period, due to increasing prevalence of neurological disorders in the population.
The neuromodulation market report analyzes factors affecting neuromodulation market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The neuromodulation market report also includes the profiles of key neuromodulation manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the neuromodulation market are Abbott, Boston Scientific Corporation, Integer Holdings Corporation, Magstim, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., Nevro Corp., Synapse Biomedical Inc., and Soterix Medical Inc. among others.
Reason to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Neuromodulation Market
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Neuromodulation Market, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
Complete Report is Available at: http://bit.ly/2O2D9pj
About Us:
The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuromodulation Market to 2025 | Top Key Players are Abbott, Boston Scientific Corporation, Integer Holdings Corporation, Magstim, Medtronic, NeuroPace, Inc., NeuroSigma, Inc., Nevro Corp here
News-ID: 1279915 • Views: …
More Releases from The Insight Partners

Future of Clean Energy - Complete Guide (PDF)
With the mounting population and industrialization, the demand for energy is also rising at the global level. This has boosted the need for alternative energy sources, as traditional energy resources such as fossil fuels are directing to environmental pollution. Clean alternative options such as solar and wind curb immense carbon emissions and their negative impact on the environment and help balance the energy supply and demand. Thus, the rise in…

Mechanical Thrombectomy Devices Market Size, Demand, Share, Analysis with Focus …
An off-the-shelf report on Mechanical Thrombectomy Devices Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade…

Containment Piping System Market Size, Demand, Analytical Overview, Comprehensiv …
Containment Piping System Market study by "The Insight Partners" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies' revenues. It concludes with precise and…

Nutraceuticals - An Ultimate PDF Guide
Consumers in developed and some developing countries are highly attracted to functional products, mainly on account of the added health and wellness benefits. Nutraceuticals are associated with various medicinal and health benefits, such as to improve the function of the immune system, boost gut health, and others. Rising healthcare costs, coupled with the increasing geriatric population across the world, propels the adoption of various nutraceuticals such as dietary supplements, functional…
More Releases for Neuromodulation
Neuromodulation Market worth $10.4 billion by 2027
Neuromodulation Market is projected to grow from USD 6.0 billion in 2022 to USD 10.4 billion by 2027, at a CAGR of 11.8% from 2022 to 2027, according to a new report by MarketsandMarkets™. The market is driven by government support for research on neurological disorder along with increasing prevalence of neurological disorders. Emerging economies are expected to provide lucrative growth opportunities for the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=921&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral
The internal neuromodulation…
Neuromodulation Market worth $11.0 billion by 2028
Browse 195 market data Tables and 39 Figures spread through 210 Pages and in-depth TOC on "Neuromodulation Market by Type (Internal (Spinal Cord Stimulation, Deep Brain Stimulation), External (Transcranial Magnetic Stimulation), Application (Tremor, Epilepsy, Parkinson's Disease, Depression, Gastroparesis), and Region - Global Forecast to 2028
Neuromodulation Market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at…
Neuromodulation Market: Charting Future Frontiers for 2030
The Neuromodulation market was valued USD 6.5 Billion in 2023 and projected to reach USD 15.3 Billion by 2030, growing at a CAGR of 13.0% during the forecast period of 2024-2030.
The Neuromodulation Market report studies the competitive environment of the Neuromodulation Market based on company profiles and their efforts to increase product value and production. The Neuromodulation Market report discusses various factors driving or restraining the market, which will help…
Incontinence Neuromodulation Market - Reclaiming Independence, Redefining Well-b …
Newark, New Castle, USA: The "Incontinence Neuromodulation Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Incontinence Neuromodulation Market: https://www.growthplusreports.com/report/incontinence-neuromodulation-market/8696
This latest report researches the industry structure, sales, revenue,…
Neuromodulation Devices Market Insights, Forecast to 2030
The report extensively examines the global Neuromodulation Devices market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Neuromodulation Devices . For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market…
Neuromodulation Market Outlook 2022-2028
Neurological issues are characterized as problems that influence the mind as well as the nerves tracked down all through the human body and the spinal rope. Intense spinal line injury, Alzheimer's sickness, amyotrophic horizontal sclerosis (ALS), ataxia, chime paralysis, mind cancers, cerebral aneurysm, epilepsy, and seizures are a portion of the normal neurological issues. The biochemical, underlying, or electrical irregularities in the mind, spinal line, or different nerves bring about…